Economics at your fingertips  

Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals

Pierre Dubois () and Laura Lasio

American Economic Review, 2018, vol. 108, issue 12, 3685-3724

Abstract: We develop a structural model to investigate the effects of pharmaceutical price regulation on demand and on manufacturers' price-setting behavior in France. We estimate price-cost margins in a regulated market with price constraints and infer whether these constraints are binding, exploiting cost restrictions across drugs, which come from observing the same drugs in potentially price-constrained markets (France) and in markets where prices are unregulated (US and Germany). Our counterfactual simulations suggest that price constraints generated modest savings for anti-ulcer drugs in 2003–2013 (2 percent of total expenses), relative to a free pricing scenario, and shifted consumption from generic to branded drugs.

JEL-codes: C51 D24 I18 L13 L51 L65 (search for similar items in EconPapers)
Date: 2018
Note: DOI: 10.1257/aer.20140202
References: Add references at CitEc
Citations: View citations in EconPapers (3) Track citations by RSS feed

Downloads: (external link) (application/pdf) ... Oo3eLFPRt7xzGwX0l-Dc (application/zip) ... XiazF9_ci4uikJ28vE6f (application/pdf) ... doIKOmLDvcqEXZqOiuzm (application/zip)
Access to full text is restricted to AEA members and institutional subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Ordering information: This journal article can be ordered from

Access Statistics for this article

American Economic Review is currently edited by Esther Duflo

More articles in American Economic Review from American Economic Association Contact information at EDIRC.
Bibliographic data for series maintained by Michael P. Albert ().

Page updated 2021-12-28
Handle: RePEc:aea:aecrev:v:108:y:2018:i:12:p:3685-3724